Optimization of electroporation and other non‐viral gene delivery strategies for T cells

Оптимизация электропорации и других невирусных стратегий доставки генов в Т-клетки
Emily Harris, Jacob J. Elmer
2020-08-28

CAR-T therapyT-cell transfectioncationic polymers and lipidselectroporationnon-viral gene delivery
Abstract CAR‐T therapy is a particularly effective treatment for some types of cancer that uses retroviruses to deliver the gene for a chimeric antigen receptor (CAR) to a patient's T cells ex vivo. The CAR enables the T cells to bind and eradicate cells with a specific surface marker (e.g., CD19 + B cells) after they are transfused back into the patient. This treatment was proven to be particularly effective in treating non‐Hodgkin's lymphoma (NHL) and acute lymphoblastic leukemia (ALL), but the current CAR‐T cell manufacturing process has a few significant drawbacks. For example, while lentiviral and gammaretroviral transduction are both relatively effective, the process of producing viral vectors is time‐consuming and costly. Additionally, patients must undergo follow up appointments for several years to monitor them for any unanticipated side effects associated with the virus. Therefore, several studies have endeavored to find alternative non‐viral gene delivery methods that are less expensive, more precise, simple, and safe. This review focuses on the current state of the most promising non‐viral gene delivery techniques, including electroporation and transfection with cationic polymers or lipids.
1
CAR-T therapy has demonstrated particular effectiveness against non-Hodgkin’s lymphoma and acute lymphoblastic leukemia by genetically modifying patient T cells to express chimeric antigen receptors.
2
Lentiviral and gammaretroviral gene delivery are effective but require costly, time-consuming viral-vector production and long-term patient monitoring for potential vector-related adverse effects.
3
Non-viral gene delivery methods are being investigated to make CAR-T manufacturing less expensive, more precise, simpler, and safer.
4
The review evaluates electroporation and transfection using cationic polymers or lipids as promising non-viral strategies for delivering genes to T cells.

non-viral gene delivery strategies for T cells, including electroporation and transfection with cationic polymers or lipids

optimization, effectiveness, cost, precision, simplicity, and safety of these gene delivery strategies for CAR-T cell manufacturing

Publication Details
Publication Date
2020-08-28
Journal
Publisher
ISSN
Cited by
86
Access Type
Author Information
Authors
Emily Harris
Jacob J. Elmer
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%